Loading company…
PEPTIDE DOOR researches peptide-based treatments and products for toxin binding and removal.
Founded in 2002 in Takasaki, Japan, PEPTIDE DOOR researches medical treatments using peptides to bind toxins and remove them from the body. Its pep-abser products support endotoxin measurement and endotoxin removal in testing and research settings. The company also develops peptide libraries using Phage Display to identify protein interaction partners and antibody epitopes. In March 2008, it raised JPY 75 million from Tohoku Innovation Capital Corporation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in